Tell CDC: we need Novavax! TODAY is the public comment deadline.
The U.S. CDC’s Advisory Committee on Immunization Practices (ACIP) meets next week, where they are likely to decide if the 2025 Novavax vaccine is approved.
Many people, including many chronically ill and disabled people, have fewer side effects from Novavax. Some research suggests that Novavax may have higher long-term effectiveness. If you want more vaccine options, now is the time to let the CDC know!